Finance

Lists
AUTL:NASDAQ
Autolus Therapeutics PLC
1,55 US$
+1,31%
(+0,020) 1D
27 ოქტ, 12:07:45 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AUTL...
Open
1,53 US$
High
1,56 US$
Low
1,50 US$
Mkt. cap
412,55 მლნ.
Avg. vol.
1,67 მლნ.
Volume
622,31 ათ.
52-wk high
2,58 US$
52-wk low
1,18 US$
EPS
-1,05 US$
Beta
2,15
Shares outstanding
266,16 მლნ.
No. of employees
753
Open
1,53 US$
High
1,56 US$
Low
1,50 US$
Mkt. cap
412,55 მლნ.
Avg. vol.
1,67 მლნ.
Volume
622,31 ათ.
52-wk high
2,58 US$
52-wk low
1,18 US$
EPS
-1,05 US$
Beta
2,15
Shares outstanding
266,16 მლნ.
No. of employees
753
News stories
From web sources and news partners
About Autolus Therapeutics PLC
CEOChristian Itin
Employees753
Founded2014
Headquarters-
Sector-
Analyst ratings
Based on 5 analysts giving stock ratings to AUTL in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for AUTL in the last 3 months.
Highest
Current 1,55 US$
10,00 US$ (+545,16%)
Average
7,70 US$ (+396,77%)
Lowest
5,00 US$ (+222,58%)
Analyst
Recommendation
Action
Price target
Projected
Date
Gil Blum
Needham
Buy
Maintained
10,00 US$
+545,2%
10/02/2026
Unknown Analyst
Wells Fargo
Buy
Maintained
5,00 US$
+222,6%
10/02/2026
Matt Phipps
William Blair
Buy
Reiterated
-
-
09/25/2026
Emily Bodnar
H.C. Wainwright
Buy
Maintained
10,00 US$
+545,2%
09/21/2026
Rajan Sharma
Goldman Sachs
Buy
Reiterated
5,80 US$
+274,2%
08/11/2026
Salim Syed
Mizuho Securities
Buy
Maintained
10,00 US$
+545,2%
06/10/2026
Unknown Analyst
Goldman Sachs
Buy
Reiterated
5,40 US$
+248,4%
05/15/2026
Next call 14 დღეში
სამ, 10 ნოე, 15:30
Fiscal period
Q3 2026
- / -0,17 US$
Revenue / Est. (USD)
- / 40,03 მლნ.
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
21,19 მლნ.
24,29 მლნ.
26,22 მლნ.
45,69 მლნ.
Cost of goods sold
56,54 მლნ.
54,29 მლნ.
45,78 მლნ.
48,37 მლნ.
Cost of revenue
56,54 მლნ.
54,29 მლნ.
45,78 მლნ.
48,37 მლნ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
36,28 მლნ.
42,12 მლნ.
39,95 მლნ.
41,16 მლნ.
Operating expense
36,28 მლნ.
42,12 მლნ.
39,95 მლნ.
41,16 მლნ.
Total operating expenses
92,82 მლნ.
96,41 მლნ.
85,73 მლნ.
89,53 მლნ.
Operating income
-71,62 მლნ.
-72,12 მლნ.
-59,51 მლნ.
-43,84 მლნ.
Other non operating income
84,00 ათ.
-11,66 მლნ.
100,00 ათ.
15,35 მლნ.
EBT including unusual items
-78,59 მლნ.
-91,52 მლნ.
-70,74 მლნ.
-38,65 მლნ.
EBT excluding unusual items
-78,59 მლნ.
-91,17 მლნ.
-70,74 მლნ.
-38,65 მლნ.
Income tax expense
532,00 ათ.
-1,18 მლნ.
863,00 ათ.
465,00 ათ.
Effective tax rate
-0,68%
1,29%
-1,22%
-1,20%
Other operating expenses
-
-
-
-
Net income
-79,12 მლნ.
-90,33 მლნ.
-71,60 მლნ.
-39,11 მლნ.
Net profit margin
-373,30%
-371,90%
-273,09%
-85,60%
Earnings per share
-0,30
-0,34
-0,27
-0,15
Interest and investment income
4,38 მლნ.
3,23 მლნ.
2,47 მლნ.
1,88 მლნ.
Interest expense
-10,52 მლნ.
-11,01 მლნ.
-11,12 მლნ.
-12,50 მლნ.
Net interest expenses
-6,14 მლნ.
-7,78 მლნ.
-8,66 მლნ.
-10,62 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-69,08 მლნ.
-69,49 მლნ.
-56,81 მლნ.
-41,19 მლნ.
Gain or loss from assets sale
-
11,00 ათ.
2,00 ათ.
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google აპები